From conventional biologics-device combination products to advanced therapies: current state and future trends in patient-centric delivery.

Bhambhani A, Wei JY, Zhang H, Shi C

Open source

DOI
10.1016/j.addr.2026.115958
Published
2026 Sep 1
Container
Advanced drug delivery reviews
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.addr.2026.115958,
  title = {From conventional biologics-device combination products to advanced therapies: current state and future trends in patient-centric delivery.},
  author = {Bhambhani A and Wei JY and Zhang H and Shi C},
  year = {2026},
  journal = {Advanced drug delivery reviews},
  doi = {10.1016/j.addr.2026.115958},
  url = {https://doi.org/10.1016/j.addr.2026.115958}
}

RIS

TY  - JOUR
TI  - From conventional biologics-device combination products to advanced therapies: current state and future trends in patient-centric delivery.
AU  - Bhambhani A
AU  - Wei JY
AU  - Zhang H
AU  - Shi C
PY  - 2026
JO  - Advanced drug delivery reviews
DO  - 10.1016/j.addr.2026.115958
UR  - https://doi.org/10.1016/j.addr.2026.115958
ER  - 

APA

A, B., JY, W., H, Z., & C, S. (2026). From conventional biologics-device combination products to advanced therapies: current state and future trends in patient-centric delivery.. Advanced drug delivery reviews. https://doi.org/10.1016/j.addr.2026.115958

Source records